10-K Filing

BNB PLUS CORP. CIK: 744452 FY 2024

Filing Information

Form Type	10-K
Accession Number	`0001410578-24-002100`
Period End Date	20240930
Filing Date	20241217
Fiscal Year	2024
Fiscal Period	FY
XBRL Instance	apdn-20240930x10k_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 158 Income Statement 88 Cash Flow Statement 98 Stockholders Equity 42

Balance Sheet 158 line items

Line Item	Tag	Value	Unit	Period
Allowance on accounts receivable	`AllowanceForDoubtfulAccountsReceivableCurrent`	$75.00K	USD	Point-in-time
Allowance on accounts receivable	`AllowanceForDoubtfulAccountsReceivableCurrent`	$75.00K	USD	Point-in-time
Allowance on accounts receivable	`AllowanceForDoubtfulAccountsReceivableCurrent`	$75.00K	USD	Point-in-time
Allowance on accounts receivable	`AllowanceForDoubtfulAccountsReceivableCurrent`	$75.00K	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$10.10M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$10.10M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$6.43M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$6.43M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$7.15M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$7.15M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable, net of allowance for credit losses of $75,000 at September 30, 2024 and 2023	`AccountsReceivableNetCurrent`	$362.01K	USD	Point-in-time
Accounts receivable, net of allowance for credit losses of $75,000 at September 30, 2024 and 2023	`AccountsReceivableNetCurrent`	$362.01K	USD	Point-in-time
Accounts receivable, net of allowance for credit losses of $75,000 at September 30, 2024 and 2023	`AccountsReceivableNetCurrent`	$255.50K	USD	Point-in-time
Accounts receivable, net of allowance for credit losses of $75,000 at September 30, 2024 and 2023	`AccountsReceivableNetCurrent`	$255.50K	USD	Point-in-time
Inventories	`InventoryNet`	$330.03K	USD	Point-in-time
Inventories	`InventoryNet`	$330.03K	USD	Point-in-time
Inventories	`InventoryNet`	$438.59K	USD	Point-in-time
Inventories	`InventoryNet`	$438.59K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$815.97K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$815.97K	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$389.24K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$389.24K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$8.05M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$8.05M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$8.13M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$8.13M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$553.23K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$553.23K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	10.31M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	10.31M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$838.27K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$838.27K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	682,926.00	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	682,926.00	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	10.31M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	10.31M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	682,926.00	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	682,926.00	shares	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$750.00K	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$750.00K	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$750.00K	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$750.00K	USD	Point-in-time
Intangible assets	`IntangibleAssetsNetExcludingGoodwill`	$2.70M	USD	Point-in-time
Intangible assets	`IntangibleAssetsNetExcludingGoodwill`	$2.70M	USD	Point-in-time
Intangible assets	`IntangibleAssetsNetExcludingGoodwill`	$2.70M	USD	Point-in-time
Intangible assets	`IntangibleAssetsNetExcludingGoodwill`	$2.70M	USD	Point-in-time
Operating right of use asset	`OperatingLeaseRightOfUseAsset`	$1.24M	USD	Point-in-time
Operating right of use asset	`OperatingLeaseRightOfUseAsset`	$1.24M	USD	Point-in-time
Operating right of use asset	`OperatingLeaseRightOfUseAsset`	$739.16K	USD	Point-in-time
Operating right of use asset	`OperatingLeaseRightOfUseAsset`	$739.16K	USD	Point-in-time
Total assets	`Assets`	$12.79M	USD	Point-in-time
Total assets	`Assets`	$12.79M	USD	Point-in-time
Total assets	`Assets`	$13.65M	USD	Point-in-time
Total assets	`Assets`	$13.65M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$2.27M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$2.27M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$1.79M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$1.79M	USD	Point-in-time
Operating lease liability, current	`OperatingLeaseLiabilityCurrent`	$498.60K	USD	Point-in-time
Operating lease liability, current	`OperatingLeaseLiabilityCurrent`	$498.60K	USD	Point-in-time
Operating lease liability, current	`OperatingLeaseLiabilityCurrent`	$545.91K	USD	Point-in-time
Operating lease liability, current	`OperatingLeaseLiabilityCurrent`	$545.91K	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$76.44K	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$76.44K	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$58.78K	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$58.78K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.40M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.40M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.85M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.85M	USD	Point-in-time
Long term accrued liabilities	`AccountsPayableAndAccruedLiabilitiesNoncurrent`	$31.47K	USD	Point-in-time
Long term accrued liabilities	`AccountsPayableAndAccruedLiabilitiesNoncurrent`	$31.47K	USD	Point-in-time
Long term accrued liabilities	`AccountsPayableAndAccruedLiabilitiesNoncurrent`	$31.47K	USD	Point-in-time
Long term accrued liabilities	`AccountsPayableAndAccruedLiabilitiesNoncurrent`	$31.47K	USD	Point-in-time
Deferred revenue, long term	`ContractWithCustomerLiabilityNoncurrent`	$194.00K	USD	Point-in-time
Deferred revenue, long term	`ContractWithCustomerLiabilityNoncurrent`	$194.00K	USD	Point-in-time
Deferred revenue, long term	`ContractWithCustomerLiabilityNoncurrent`	$194.00K	USD	Point-in-time
Deferred revenue, long term	`ContractWithCustomerLiabilityNoncurrent`	$194.00K	USD	Point-in-time
Operating lease liability, long term	`OperatingLeaseLiabilityNoncurrent`	$739.16K	USD	Point-in-time
Operating lease liability, long term	`OperatingLeaseLiabilityNoncurrent`	$739.16K	USD	Point-in-time
Operating lease liability, long term	`OperatingLeaseLiabilityNoncurrent`	$193.25K	USD	Point-in-time
Operating lease liability, long term	`OperatingLeaseLiabilityNoncurrent`	$193.25K	USD	Point-in-time
Deferred tax liability, net	`DeferredIncomeTaxLiabilitiesNet`	$684.12K	USD	Point-in-time
Deferred tax liability, net	`DeferredIncomeTaxLiabilitiesNet`	$684.12K	USD	Point-in-time
Deferred tax liability, net	`DeferredIncomeTaxLiabilitiesNet`	$684.12K	USD	Point-in-time
Deferred tax liability, net	`DeferredIncomeTaxLiabilitiesNet`	$684.12K	USD	Point-in-time
Warrants classified as a liability	`CommonWarrantLiabilityNoncurrent`	$4.29M	USD	Point-in-time
Warrants classified as a liability	`CommonWarrantLiabilityNoncurrent`	$4.29M	USD	Point-in-time
Warrants classified as a liability	`CommonWarrantLiabilityNoncurrent`	$320.00K	USD	Point-in-time
Warrants classified as a liability	`CommonWarrantLiabilityNoncurrent`	$320.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$8.78M	USD	Point-in-time
Total liabilities	`Liabilities`	$8.78M	USD	Point-in-time
Total liabilities	`Liabilities`	$3.82M	USD	Point-in-time
Total liabilities	`Liabilities`	$3.82M	USD	Point-in-time
Commitments and contingencies (Note G)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note G)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note G)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note G)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of September 30, 2024 and 2023	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of September 30, 2024 and 2023	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of September 30, 2024 and 2023	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of September 30, 2024 and 2023	`PreferredStockValue`	-	USD	Point-in-time
Common stock, par value $0.001 per share; 200,000,000 shares authorized as of September 30, 2024 and 2023, 10,311,885 and 682,926 shares issued and outstanding as of September 30, 2024 and 2023, respectively	`CommonStockValue`	$10.31K	USD	Point-in-time
Common stock, par value $0.001 per share; 200,000,000 shares authorized as of September 30, 2024 and 2023, 10,311,885 and 682,926 shares issued and outstanding as of September 30, 2024 and 2023, respectively	`CommonStockValue`	$10.31K	USD	Point-in-time
Common stock, par value $0.001 per share; 200,000,000 shares authorized as of September 30, 2024 and 2023, 10,311,885 and 682,926 shares issued and outstanding as of September 30, 2024 and 2023, respectively	`CommonStockValue`	$683.00	USD	Point-in-time
Common stock, par value $0.001 per share; 200,000,000 shares authorized as of September 30, 2024 and 2023, 10,311,885 and 682,926 shares issued and outstanding as of September 30, 2024 and 2023, respectively	`CommonStockValue`	$683.00	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$318.81M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$318.81M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$307.40M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$307.40M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-309.67M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-309.67M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-302.45M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-302.45M	USD	Point-in-time
Applied DNA Sciences, Inc. stockholders' equity	`StockholdersEquity`	$4.95M	USD	Point-in-time
Applied DNA Sciences, Inc. stockholders' equity	`StockholdersEquity`	$4.95M	USD	Point-in-time
Applied DNA Sciences, Inc. stockholders' equity	`StockholdersEquity`	$9.14M	USD	Point-in-time
Applied DNA Sciences, Inc. stockholders' equity	`StockholdersEquity`	$9.14M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-174.53K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-174.53K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-78.75K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-78.75K	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.97M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.97M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.91M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.91M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.87M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.87M	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$12.79M	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$12.79M	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$13.65M	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$13.65M	USD	Point-in-time

Income Statement 88 line items

Line Item	Tag	Value	Unit	Period
Total revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$3.43M	USD	Annual
Total revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$3.43M	USD	Annual
Total revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$13.37M	USD	Annual
Total revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$13.37M	USD	Annual
Total cost of revenues	`CostOfRevenue`	$7.83M	USD	Annual
Total cost of revenues	`CostOfRevenue`	$7.83M	USD	Annual
Total cost of revenues	`CostOfRevenue`	$2.41M	USD	Annual
Total cost of revenues	`CostOfRevenue`	$2.41M	USD	Annual
Gross profit	`GrossProfit`	$5.53M	USD	Annual
Gross profit	`GrossProfit`	$5.53M	USD	Annual
Gross profit	`GrossProfit`	$1.02M	USD	Annual
Gross profit	`GrossProfit`	$1.02M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$11.45M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$11.45M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$12.75M	USD	Annual
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$12.75M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$3.74M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$3.74M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$3.59M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$3.59M	USD	Annual
Total operating expenses	`OperatingExpenses`	$16.49M	USD	Annual
Total operating expenses	`OperatingExpenses`	$16.49M	USD	Annual
Total operating expenses	`OperatingExpenses`	$15.04M	USD	Annual
Total operating expenses	`OperatingExpenses`	$15.04M	USD	Annual
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-14.02M	USD	Annual
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-14.02M	USD	Annual
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-10.95M	USD	Annual
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-10.95M	USD	Annual
Interest income	`InvestmentIncomeInterest`	$75.33K	USD	Annual
Interest income	`InvestmentIncomeInterest`	$75.33K	USD	Annual
Interest income	`InvestmentIncomeInterest`	$176.30K	USD	Annual
Interest income	`InvestmentIncomeInterest`	$176.30K	USD	Annual
Transaction costs allocated to warrant liabilities	`TransactionCostAllocatedToWarrantLiabilities`	$-633.20K	USD	Annual
Transaction costs allocated to warrant liabilities	`TransactionCostAllocatedToWarrantLiabilities`	$-633.20K	USD	Annual
Unrealized gain on change in fair value of warrants classified as a liability	`FairValueAdjustmentOfWarrants`	$-854.40K	USD	Annual
Unrealized gain on change in fair value of warrants classified as a liability	`FairValueAdjustmentOfWarrants`	$-854.40K	USD	Annual
Unrealized gain on change in fair value of warrants classified as a liability	`FairValueAdjustmentOfWarrants`	$-9.43M	USD	Annual
Unrealized gain on change in fair value of warrants classified as a liability	`FairValueAdjustmentOfWarrants`	$-9.43M	USD	Annual
Unrealized loss on change in fair value of warrants classified as a liability - warrant modification	`UnrealizedLossOnChangeInFairValueOfWarrants`	$-394.00K	USD	Annual
Unrealized loss on change in fair value of warrants classified as a liability - warrant modification	`UnrealizedLossOnChangeInFairValueOfWarrants`	$-394.00K	USD	Annual
Loss on issuance of warrants	`LossOnIssuanceOfWarrants`	$1.63M	USD	Annual
Loss on issuance of warrants	`LossOnIssuanceOfWarrants`	$1.63M	USD	Annual
Other (expense) income, net	`OtherNonoperatingIncomeExpense`	$-8.88K	USD	Annual
Other (expense) income, net	`OtherNonoperatingIncomeExpense`	$-8.88K	USD	Annual
Other (expense) income, net	`OtherNonoperatingIncomeExpense`	$642.00	USD	Annual
Other (expense) income, net	`OtherNonoperatingIncomeExpense`	$642.00	USD	Annual
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-7.09M	USD	Annual
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-7.09M	USD	Annual
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-10.02M	USD	Annual
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-10.02M	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	Annual
NET LOSS	`ProfitLoss`	$-7.09M	USD	Annual
NET LOSS	`ProfitLoss`	$-7.09M	USD	Annual
NET LOSS	`ProfitLoss`	$-10.02M	USD	Annual
NET LOSS	`ProfitLoss`	$-10.02M	USD	Annual
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-75.86K	USD	Annual
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-75.86K	USD	Annual
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-95.78K	USD	Annual
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-95.78K	USD	Annual
NET LOSS attributable to Applied DNA Sciences, Inc.	`NetIncomeLoss`	$-9.95M	USD	Annual
NET LOSS attributable to Applied DNA Sciences, Inc.	`NetIncomeLoss`	$-9.95M	USD	Annual
NET LOSS attributable to Applied DNA Sciences, Inc.	`NetIncomeLoss`	$-6.99M	USD	Annual
NET LOSS attributable to Applied DNA Sciences, Inc.	`NetIncomeLoss`	$-6.99M	USD	Annual
Deemed dividend related to warrant modifications	`DeemedDividendRelatedToWarrantModifications`	$233.09K	USD	Annual
Deemed dividend related to warrant modifications	`DeemedDividendRelatedToWarrantModifications`	$233.09K	USD	Annual
NET LOSS attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-9.95M	USD	Annual
NET LOSS attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-9.95M	USD	Annual
NET LOSS attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-7.23M	USD	Annual
NET LOSS attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-7.23M	USD	Annual
Net loss per share attributable to common stockholders-basic (in dollars per share)	`EarningsPerShareBasic`	$-1.82	USD	Annual
Net loss per share attributable to common stockholders-basic (in dollars per share)	`EarningsPerShareBasic`	$-1.82	USD	Annual
Net loss per share attributable to common stockholders-basic (in dollars per share)	`EarningsPerShareBasic`	$-15.21	USD	Annual
Net loss per share attributable to common stockholders-basic (in dollars per share)	`EarningsPerShareBasic`	$-15.21	USD	Annual
Net loss per share attributable to common stockholders-diluted (in dollars per share)	`EarningsPerShareDiluted`	$-1.82	USD	Annual
Net loss per share attributable to common stockholders-diluted (in dollars per share)	`EarningsPerShareDiluted`	$-1.82	USD	Annual
Net loss per share attributable to common stockholders-diluted (in dollars per share)	`EarningsPerShareDiluted`	$-15.21	USD	Annual
Net loss per share attributable to common stockholders-diluted (in dollars per share)	`EarningsPerShareDiluted`	$-15.21	USD	Annual
Weighted average shares outstanding-basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	3.97M	shares	Annual
Weighted average shares outstanding-basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	3.97M	shares	Annual
Weighted average shares outstanding-basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	653,771.00	shares	Annual
Weighted average shares outstanding-basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	653,771.00	shares	Annual
Weighted average shares outstanding-diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	653,771.00	shares	Annual
Weighted average shares outstanding-diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	653,771.00	shares	Annual
Weighted average shares outstanding-diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	3.97M	shares	Annual
Weighted average shares outstanding-diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	3.97M	shares	Annual

Cash Flow Statement 98 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-7.09M	USD	Annual
Net loss	`ProfitLoss`	$-7.09M	USD	Annual
Net loss	`ProfitLoss`	$-10.02M	USD	Annual
Net loss	`ProfitLoss`	$-10.02M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$696.42K	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$696.42K	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.36M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.36M	USD	Annual
Gain on sale of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$6.08K	USD	Annual
Gain on sale of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$6.08K	USD	Annual
Write-off of property and equipment	`WriteOffOfPropertyAndEquipment`	$62.00K	USD	Annual
Write-off of property and equipment	`WriteOffOfPropertyAndEquipment`	$62.00K	USD	Annual
Shares issued Spindle earnout	`EarnoutExpenseAssetPurchaseAgreement`	$17.12K	USD	Annual
Shares issued Spindle earnout	`EarnoutExpenseAssetPurchaseAgreement`	$17.12K	USD	Annual
Unrealized gain on change in fair value of warrants classified as a liability	`UnrealizedGainOnChangeInFairValueOfWarrants`	$854.40K	USD	Annual
Unrealized gain on change in fair value of warrants classified as a liability	`UnrealizedGainOnChangeInFairValueOfWarrants`	$854.40K	USD	Annual
Unrealized gain on change in fair value of warrants classified as a liability	`UnrealizedGainOnChangeInFairValueOfWarrants`	$9.43M	USD	Annual
Unrealized gain on change in fair value of warrants classified as a liability	`UnrealizedGainOnChangeInFairValueOfWarrants`	$9.43M	USD	Annual
Unrealized loss on change in fair value of warrants classified as a liability-warrant modification	`UnrealizedLossOnChangeInFairValueOfWarrants`	$-394.00K	USD	Annual
Unrealized loss on change in fair value of warrants classified as a liability-warrant modification	`UnrealizedLossOnChangeInFairValueOfWarrants`	$-394.00K	USD	Annual
Transaction costs allocated to warrant liabilities	`RegisteredDirectOfferingCosts`	$633.20K	USD	Annual
Transaction costs allocated to warrant liabilities	`RegisteredDirectOfferingCosts`	$633.20K	USD	Annual
Loss on issuance of warrants	`LossOnIssuanceOfWarrants`	$1.63M	USD	Annual
Loss on issuance of warrants	`LossOnIssuanceOfWarrants`	$1.63M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$572.29K	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$572.29K	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$1.03M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$1.03M	USD	Annual
Change in provision for bad debts	`ProvisionForDoubtfulAccounts`	$-239.04K	USD	Annual
Change in provision for bad debts	`ProvisionForDoubtfulAccounts`	$-239.04K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$106.51K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$106.51K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-3.05M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-3.05M	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$-272.22K	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$-272.22K	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$108.56K	USD	Annual
Inventories	`IncreaseDecreaseInInventories`	$108.56K	USD	Annual
Prepaid expenses, other current assets and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-767.81K	USD	Annual
Prepaid expenses, other current assets and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-767.81K	USD	Annual
Prepaid expenses, other current assets and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$426.73K	USD	Annual
Prepaid expenses, other current assets and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$426.73K	USD	Annual
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-480.44K	USD	Annual
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-480.44K	USD	Annual
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-1.35M	USD	Annual
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-1.35M	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenues`	$-17.65K	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenues`	$-17.65K	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenues`	$-293.12K	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenues`	$-293.12K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-6.22M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-6.22M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-13.71M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-13.71M	USD	Annual
Cash paid for Spindle asset purchase	`PaymentsToAcquireIntangibleAssets`	$1.06M	USD	Annual
Cash paid for Spindle asset purchase	`PaymentsToAcquireIntangibleAssets`	$1.06M	USD	Annual
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$45.00K	USD	Annual
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$45.00K	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$407.90K	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$407.90K	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$78.45K	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$78.45K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.10M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.10M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-407.90K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-407.90K	USD	Annual
Net proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$394.00	USD	Annual
Net proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$394.00	USD	Annual
Net proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$13.40M	USD	Annual
Net proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$13.40M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$13.40M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$13.40M	USD	Annual
Net decrease in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-720.71K	USD	Annual
Net decrease in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-720.71K	USD	Annual
Net decrease in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-7.31M	USD	Annual
Net decrease in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-7.31M	USD	Annual
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$15.22M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$15.22M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.90M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.90M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.18M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.18M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$15.22M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$15.22M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.90M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.90M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.18M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.18M	USD	Point-in-time
Common stock issued for Spindle asset purchase	`StockIssued1`	$952.50K	USD	Annual
Common stock issued for Spindle asset purchase	`StockIssued1`	$952.50K	USD	Annual
Deemed dividend warrant modifications	`DeemedDividendWarrantModifications`	$233.09K	USD	Annual
Deemed dividend warrant modifications	`DeemedDividendWarrantModifications`	$233.09K	USD	Annual
Deferred tax liability for Spindle asset purchase	`LiabilitiesAssumed1`	$684.12K	USD	Annual
Deferred tax liability for Spindle asset purchase	`LiabilitiesAssumed1`	$684.12K	USD	Annual
Leased assets obtained in exchange for new operating lease liabilities	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$1.55M	USD	Annual
Leased assets obtained in exchange for new operating lease liabilities	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$1.55M	USD	Annual
Property and equipment acquired and included in accounts payable	`PropertyPlantAndEquipmentAcquiredAndIncludedInAccountsPayable`	$3.48K	USD	Annual
Property and equipment acquired and included in accounts payable	`PropertyPlantAndEquipmentAcquiredAndIncludedInAccountsPayable`	$3.48K	USD	Annual

Stockholders Equity 42 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.97M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.97M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.91M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.91M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.87M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.87M	USD	Point-in-time
Beginning Balance (in shares)	`CommonStockSharesOutstanding`	10.31M	shares	Point-in-time
Beginning Balance (in shares)	`CommonStockSharesOutstanding`	10.31M	shares	Point-in-time
Beginning Balance (in shares)	`CommonStockSharesOutstanding`	682,926.00	shares	Point-in-time
Beginning Balance (in shares)	`CommonStockSharesOutstanding`	682,926.00	shares	Point-in-time
Stock based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$-572.29K	USD	Annual
Stock based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$-572.29K	USD	Annual
Stock based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.03M	USD	Annual
Stock based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.03M	USD	Annual
Common stock issued (In shares)	`StockIssuedDuringPeriodSharesNewIssues`	4,501.00	shares	Annual
Common stock issued (In shares)	`StockIssuedDuringPeriodSharesNewIssues`	4,501.00	shares	Annual
Deemed dividend - warrant repricing	`AdjustmentsToAdditionalPaidInCapitalDeemedDividendWarrantRepricing`	$155.33K	USD	Annual
Deemed dividend - warrant repricing	`AdjustmentsToAdditionalPaidInCapitalDeemedDividendWarrantRepricing`	$155.33K	USD	Annual
Deemed dividend - warrant repricing	`AdjustmentsToAdditionalPaidInCapitalDeemedDividendWarrantRepricing`	$6.40M	USD	Point-in-time
Deemed dividend - warrant repricing	`AdjustmentsToAdditionalPaidInCapitalDeemedDividendWarrantRepricing`	$6.40M	USD	Point-in-time
Common stock and pre-funded warrants issued in public offering, net of offering costs	`SharesAndPreFundedWarrantsIssuedInPublicOffering`	$10.53M	USD	Annual
Common stock and pre-funded warrants issued in public offering, net of offering costs	`SharesAndPreFundedWarrantsIssuedInPublicOffering`	$10.53M	USD	Annual
Share issued upon warrant exercises	`StockIssuedDuringPeriodValueUponExerciseOfWarrants`	$4.94K	USD	Annual
Share issued upon warrant exercises	`StockIssuedDuringPeriodValueUponExerciseOfWarrants`	$4.94K	USD	Annual
Common stock issued for Spindle asset purchase	`StockIssuedDuringPeriodValuePurchaseOfAssets`	$952.50K	USD	Annual
Common stock issued for Spindle asset purchase	`StockIssuedDuringPeriodValuePurchaseOfAssets`	$952.50K	USD	Annual
Common stock issued for Spindle asset purchase	`StockIssuedDuringPeriodValuePurchaseOfAssets`	$17.12K	USD	Annual
Common stock issued for Spindle asset purchase	`StockIssuedDuringPeriodValuePurchaseOfAssets`	$17.12K	USD	Annual
Net loss	`ProfitLoss`	$-7.09M	USD	Annual
Net loss	`ProfitLoss`	$-7.09M	USD	Annual
Net loss	`ProfitLoss`	$-10.02M	USD	Annual
Net loss	`ProfitLoss`	$-10.02M	USD	Annual
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.97M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.97M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.91M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.91M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.87M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.87M	USD	Point-in-time
Ending Balance (in shares)	`CommonStockSharesOutstanding`	10.31M	shares	Point-in-time
Ending Balance (in shares)	`CommonStockSharesOutstanding`	10.31M	shares	Point-in-time
Ending Balance (in shares)	`CommonStockSharesOutstanding`	682,926.00	shares	Point-in-time
Ending Balance (in shares)	`CommonStockSharesOutstanding`	682,926.00	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.